Drug makers keen on selection of innovative pharmaceutical firms

Published: 2012-03-14 07:00:00

Updated: 2012-03-14 07:00:00

Aside from their legal action against the government’s plan to slash drug prices in April, all eyes in the domestic pharmaceutical industry are on the Ministry for Health, Welfare and Family Affair's decision on the designation of innovative pharmaceutical firms.

With the ministry’s detailed s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK